Dr Butterworth’s practice was a member of TBAS, a Department of Environment, Food and Rural Affairs-funded (Defra) project administered by Farmcare Solutions Ltd which provides advice to eligible farmers via its veterinary partners.
The farm to which the charges relate to was owned by Dr Bexon’s partner. It had no cattle on-site (though was still eligible for the TBAS).
Dr Butterworth was charged with signing a TBAS visit report, in which he was named as the TBAS advisor, relating to a visit to the farm in February 2023 which had, in fact, not taken place and then subsequently signed a report about a follow-up visit in July 2023 which also hadn’t taken place.
Dr Bexon was charged with signing the same two false reports as a representative of the farm in question.
Both faced a secondary charge that their actions were dishonest, misleading and risked undermining procedures relating to public health and animal welfare.
Dr Butterworth and Dr Bexon admitted all the charges against them and that these charges amounted to serious professional misconduct.
The Committee also found that their actions amounted to serious professional misconduct in that they had breached three of the five key principles in the Code of Professional Conduct relating to: honesty and integrity; client confidentiality and trust; and professional accountability.
The Committee also found that the actions of both veterinary surgeons had breached the ’10 principles of certification’ outlined in the supporting guidance to the Code.
Considering Mr Butterworth’s conduct, the Committee found that there were a number of aggravating factors including: the premeditated nature of the conduct as he was the driving force behind the deceit, the fact there was financial gain as his practice would have been paid for the non-existent visits, breach of confidentiality for the farmer, breach of client trust for Farmcare Solutions Ltd, and abuse of professional position as a TBAS advisor.
For Dr Bexon the aggravating factors were breach of confidentiality for the farmer, breach of client trust for Farmcare Solutions Ltd, and the fact that, as a TBAS advisor, she should have known that physical visits to farms within the scheme were mandatory.
Paul Morris, chairing the Disciplinary Committee and speaking on its behalf, said: “The Committee considered both respondents’ conduct was liable to have a seriously detrimental effect on the reputation of the profession and undermined public confidence in the profession and the TBAS process.
"The Committee considered that members of the public would be deeply troubled that registered veterinary surgeons had behaved in this way.”
At the hearing the Committee received a large number of positive testimonials for Dr Butterworth, including three given directly to the Committee – one from a veterinary surgeon colleague and two from farmer clients.
The Committee also considered his lack of previous disciplinary history and otherwise unblemished career, open and frank admissions at an early stage, insight into his misconduct, genuine remorse and positive reflection, efforts to avoid a repetition of behaviours and evidence of a more mature approach to management, lapse of time since the incident.
Taking everything into account the Committee decided reprimanding Dr Butterworth and warning him with regard to future conduct was the most appropriate and proportionate response.
Paul added: “The Committee did give serious consideration to suspending Dr Butterworth’s registration with the College.
"Such a sanction would have sent out a clear message that this sort of behaviour is absolutely not to be tolerated.
"However, in light of the extensive mitigation, his honesty and significant insight throughout these proceedings and the unlikeliness of behaviour of this type ever being repeated, the Committee considered the public would not be best served by suspending an otherwise exemplary veterinary surgeon and that such a sanction would be disproportionate and punitive.”
"In such circumstances, the Committee was satisfied that a reprimand and warning not to behave in this way again, would provide adequate protection to animals and would satisfy the public interest.
"The Committee was persuaded that Dr Butterworth would be most unlikely to make such a flawed set of decisions again.
"Notwithstanding the serious nature of Dr Butterworth’s conduct, the Committee was satisfied that a fully informed member of the public would not be shocked if he were allowed to continue to practise.”
The Committee also received a significant number of positive testimonials for Dr Bexon, with three veterinary surgeon colleagues giving oral evidence to the Committee.
The Committee also considered her lack of disciplinary history and hitherto unblemished career, her open and frank admissions, her insight, remorse and positive reflections, her efforts to avoid repetition of the behaviours and the lapse of time since the event.
Taking everything into account, the Committee decided to reprimand Dr Bexon.
Paul said: “This was not a case where she had been motivated by any financial gain.
"Indeed, everything the Committee had read and heard about her indicated the opposite and furthermore, it was apparent that she had nothing to gain by her actions beyond satisfying Dr Butterworth.
"As already stated, the Committee acknowledged that the role played by Dr Bexon was less than that played by Dr Butterworth.
"Moreover, there was a power imbalance at play and Dr Butterworth was able to take advantage of, albeit unknowingly, Dr Bexon’s lack of self-confidence.”
"The Committee has already indicated that it believed the likelihood of her repeating such behaviour to be non-existent.
"Her significant insight, together with the reflection and remedial work she has undertaken are as much as any person could do.
"She had truly learnt her lesson in the harshest of ways.
"In the Committee’s view she did not represent any risk to animals or the public, indeed quite the contrary as she is a very able vet, in high demand by her clients.”
www.rcvs.org.uk/disciplinary
Intervet has announced that its bluetongue vaccine, Bovilis® BTV8 has been granted a licence by the Veterinary Medicines Directorate (VMD). The licence, which is the first for a bluetongue vaccine in the UK, sets out dose rates and treatment regimes for the product use.
The recommended dose rates for animal over one month of age are as follows:
Sheep – 1 x 1ml, injected subcutaneously.
Cattle - 2 x 1ml, approximately three weeks apart, injected subcutaneously.
In successive years, re-vaccination should be given two weeks prior to the risk period.
Treated animals should have protective immunity three weeks after the initial course. Bovilis BTV8 should only be administered to healthy animals. Treated stock may have a slight swelling at the site of injection.
The vaccine must be stored at between 2ºC – 8ºC and, once opened, should be used within eight hours. The vaccine is available in 20ml and 50ml bottles. The licence recommends the use of multi injection vaccination systems.
Intervet will be supplying a discounted 1ml vaccination gun into the market.
The BVA is calling on Defra and the APHA to take an innovative approach to capturing farm animal post-mortem data, after its Voice of the Veterinary Profession survey found that 90% of production animal vets now conduct their own PMs.
In 2014, there was a 31% increase in production animal vets carrying out their own PMs following post mortem laboratory closures, yet most vets keep this PM data at their practice, with less than 5% inputting it into a national system such as NADIS, AHT or APHA and less than 1% to a benchmarking group.
Sean Wensley BVA President said: "We have heard a lot about big data and its positive uses economically and socially. Disease surveillance could be a shining example of where big data and innovative data capture comes into its own. In a global world, where diseases such as Schmallenberg and bluetongue can emerge in our livestock without having previously been seen on these shores, being able to quickly join up the dots of disparate disease data is vital.
"We understand that Defra and APHA must make difficult choices due to economic pressures and we very much welcome research already utilising post mortem data such as the Agriculture and Horticulture Development Board’s Fallen Stock Project. What we now need is clear communications and guidance on carcase collection and access to PM examination arrangements together with a determination to see this as an opportunity to innovate, exploring how digital technology can help vets in the field record and capture data that feed into national databases and help us to see the bigger picture."
BVA is asking that all vets affected by laboratory closures are clearly informed about alternative arrangements for carcase collection and PMs, with 63% of vets affected by laboratory closures reporting that carcase collection in their local area was not working well.
BVA is calling on government and industry to lead in developing new and cost efficient ways to capture and analyse disease and surveillance data, drawing on innovations in digital technology and big data analysis.
Photograph courtesy BVA
The National Office of Animal Health has released two films to help industry and consumers understand issues surrounding the use of animal medicines in the food chain.
A film made for the food chain industry titled "Animal Medicines in Food Production - The Food Industry Perspective" has been produced to help industry understand the levels of awareness and concerns that consumers have.
A second film, "Animal Medicines in Food Production - Challenging the Myths" is aimed at consumers and looks at some of the myths surrounding the use of animal medicines in livestock production.
Phil Sketchley, Chief Executive of NOAH, said that while the public was generally supportive of the use of animal medicines in farm production, there was a knowledge gap among consumers about the way that medicines were used: "It was interesting to discover how much people knew about medicines in food production. There were some very positive attitudes among consumers, particularly towards the way British farmers care for their animals. But there were still some areas of concern, for example with the belief among a large number of people that growth hormones were still being used on UK farms, despite the fact they have been banned since 1988.
"The industry film should help people involved in food production understand what consumers are thinking when it comes to animal medicines. Animal health and welfare and ensuring sick animals are treated is a big issue, and food producers and retailers need to be able to communicate clearly with consumers on the subject of animal medicines.
"It is important there is transparency on all issues of animal health and welfare."
Defra has announced that the Bluetongue Protection Zone will be extended again on Monday 21 July, following the delivery by Intervet of almost 2 million additional doses of Bluetongue serotype 8 (BTV-8) vaccine. Vaccination is only permitted within the Protection Zone. In accordance with the Bluetongue vaccination plan, the Protection Zone will be extended to cover Worcestershire and the districts in North Yorkshire (Scarborough, Ryedale, Hambleton & Harrogate), Cheshire (Macclesfield, Congleton & Crewe and Nantwich) and Greater Manchester (Rochdale, Oldham, Tameside and Stockport) previously in the Surveillance Zone. Defra will continue to roll out vaccination as vaccine is delivered, in line with the vaccination roll-out plan. The additional vaccine is available for use in the existing Protection Zone from today. Livestock keepers in the areas coming into the Protection Zone will be able to obtain the vaccine from Monday. However, they are encouraged to order vaccine so that they can protect their livestock at the earliest opportunity. Protection Zone restrictions will apply to those keepers coming into the extended zone. Animals can only be moved out of the Protection Zone if they are vaccinated, naturally immune or moving for slaughter, subject to meeting certain conditions. Please refer to the Defra website for further guidance. Defra also confirmed that the Merial BTV-8 vaccine has been awarded a provisional marketing authorisation from the Veterinary Medicines Directorate. The granting of a provisional marketing authorisation is an important step in confirming that the vaccine will be safe and effective. On 11 June, Defra placed an order with Merial to deliver 13 million doses of BTV-8 vaccine, eight million for use in England and five million for use in Wales.
According to the results of DairyCheck 2008, Intervet/Schering-Plough Animal Health's subsidised milk testing service, 65% of herds tested positive for IBR infection, 69% positive for Leptospirosis and the majority of herds tested showed evidence of previous BVD exposure.
According to Intervet/Schering Plough, it is widely known that exposure levels of these three endemic diseases are high, yet many producers don't see the hidden losses. Making use of DairyCheck can demonstrate infection levels on an individual unit and help encourage a control and management programme to be put in place
Vet adviser Ruth Vernon said: "It can be a case of 'out of sight, out of mind'. After the initial infection, cows may appear healthy, but be suffering from the effects of immune suppression as a result of BVD virus infection. This results in herd performance that is often below expected levels."
"When the news is good - and on average around 33% of DairyCheck tested herds were found to be clear of all three diseases - farmers need guidance and advice on keeping a naïve herd clear of disease.
"Taking time to explain how to incorporate biosecurity measures on a day-to-day basis as well as quarantine and vaccination programmes can significantly improve the health status of previously infected units."
Further information on DairyCheck is available from Intervet/Schering-Plough Account Managers.
The Farm Animal Welfare Council (FAWC) has launched its "Report on the implications of castration and tail docking for the welfare of lambs".
The report considers the implications of castration and tail docking for the welfare of lambs and reiterates FAWC's earlier view that castration and tail docking of lambs are mutilations which should not be undertaken without strong justification.
Professor Wathes, Chairman of FAWC, said: "FAWC believes that scientifically based advice can now be given that will minimise the suffering arising from castration and tail docking."
He continued "If castration is warranted, some methods cause more suffering than others and pain relief should be given once practical methods of delivering local anaesthetics and analgesics have been developed."
The full report is available for download at: http://www.fawc.org.uk/
The RSPCA has announced that it will continue its fight to stop the Government's planned cull of badgers after MPs voted against an opposition motion to reverse the Government's strategy aimed at combating bovine TB.
MPs voted 299 to 250 against proposals to stop the cull going ahead in two pilot areas in Somerset and Gloucestershire - a narrower margin than the Government has in the House of Commons despite the three-line whip enforced.
RSPCA chief executive Gavin Grant said: "We fight on. This vote flies in the face of scientific and public opinion. We are grateful to those MPs who spoke out against the cull and particularly those who defied the Government's three line whip.
"There can be little doubt that had MPs been free to express their views through a free vote there would have been a large majority against the cull as there was last October.
"The only real way forward is the vaccination of both cattle and badgers, better biosecurity and control of cattle movements."
The debate follows a report issued by the EFRA select committee which said more investment is urgently needed into vaccination as a solution for bovine TB.
One of the earliest decisions of this government was to cancel five of the six badger vaccination projects planned - a policy the RSPCA believes was short-sighted.
RSPCA chief executive Gavin Grant said: "Much more needs to be done to bring forward the timetable for the development of effective oral vaccination programmes for both cattle and badgers as the EFRA report says.
"Meanwhile we stand ready to work with those who want to vaccinate and save lives rather than cull and kill."
Initial laboratory tests on the samples taken this morning from the cattle on the holding in Surrey where disease was suspected have indicated the presence of Foot and Mouth Disease. On the basis of these initial laboratory results and clinical symptoms Debby Reynolds, UK Chief Veterinary Officer (CVO), has confirmed Foot and Mouth Disease. The farm comprises a number of separate parcels of land and a single Protection Zone will be put in place which extends a 3 kilometres radius from each of them, and a Surveillance Zone of 10 kilometres radius beyond that. Footpaths will be closed in the Protection Zone.
The March 2025 Cattle Highlights Report from the Royal GD in the Netherlands has revealed that the proportion of paromomycin-resistant isolates has jumped from 48% in 2021 to 72% in 2024.
The report also highlights an increase in the detection of cryptosporidiosis in calves up to 14 days of age.
MSD says that while it is unclear whether paromomycin is being used to treat E.coli or cryptosporidiosis, the rising use of the antibiotic could be contributing to greater exposure and increased resistance in E.coli K99.
Kat Baxter-Smith MRCVS (pictured), a vet advisor at MSD Animal Health, said: “What we need now is a mindset shift—moving away from routine antibiotic use and towards a more robust, preventative management strategy.
“It’s not about eliminating treatment altogether but using it only when it is really needed.”
“Vaccination, clean pens, and ensuring that every calf receives the right volume and quality of colostrum are the real cornerstones of effective scour control.
“Using vaccines such as Bovilis Rotavec Corona for rotavirus, coronavirus, and E.coli and Bovilis Cryptium for Cryptosporidium parvum is one of the most effective ways to reduce the incidence of neonatal diarrhoea.
"By vaccinating the dam, we ensure the calf has the best possible immunity at birth by ingesting the fortified colostrum and transition milk in the first days of life, which significantly reduces reliance on antibiotics and minimises disease risks.”
The report emphasises best-practice principles such as effective colostrum management, good hygiene and housing, balanced dry cow transition and strategic vaccination of the dam.
The report also recommends halofuginone (Halocur) as the first-line treatment for cryptosporidiosis, due to its targeted action and significantly lower risk of contributing to AMR.
Kat added: "By embracing these proactive strategies, vets and farmers can take a crucial step towards safeguarding calf health, reducing reliance on antibiotics, and combating the growing threat of antimicrobial resistance.”
https://issuu.com/gezondheidsdienstvoordieren/docs/highlights_report_cattle-march_2025
The project, which launched in September 2022 and was funded by Boehringer Ingelheim, has given subsidised respiratory pathogen investigations to over 300 farms so far.
The investigations revealed a mixture of agents, including: mycoplasma (37%), IBR (6%), P13 (12%), coronavirus (38%), histophilus (48%), RSV (30%), mannheimia (64%), and pasteurella (94%).
Following each investigation, discussions were held between farmer and vet about taking a more preventative approach, considering things like biosecurity, immunity, housing, environmental management, vaccination and treatment protocols.
CVS says the investigations have also enabled its vets to target the right vaccine to the right farm to cover the main risk periods for those animals.
Vaccinations have been timed in relation to peaks in clinical cases and pre-stress periods - such as weaning, group movements or transport to ensure animals are protected against the correct pathogen effectively.
CVS says that taking this preventative herd health measure has resulted in significantly fewer antibiotics being required to treat respiratory infection and disease in the past year.
Steven Carragher, Quality Improvement Farm Lead for CVS and Senior Veterinary Surgeon at Alnorthumbria Vets, said: “Though only running for just over two years, our programme is already yielding significant data, and we’re using this evidence to help each farm successfully implement a range of measures to help prevent and vaccinate against pneumonia – and to reduce antibiotic use.
Photo: www.depositphotos.com
IDT Biologika and Hysolv Animal Health have announced the publication of A guide to oedema disease in pigs, a six-page booklet written to help pig producers understand the causes, effects and treatment of this ailment.
Author, F Javier Salquero, an independent European veterinary specialist in porcine health management, outlines the risk factors, how to identify oedema disease, current methods of treatment and prevention strategies. The booklet includes a table of the symptoms to be expected in new-born, suckling, post-weaned, grower-finishers and adult pigs.
The booklet concludes that treatment of oedema disease is generally unsuccessful and most pigs showing clinical signs die. However, preventive measures include adjustment of feeding regimes, stress reduction, improved biosecurity and vaccination.
Hysolv director, Richard Brealey said: "Oedema is a widespread, lethal and economically-important disease in pigs, and there is increasing pressure in Europe to reduce the use of antibiotics in livestock. Fully understanding this disease is a first step to control and prevention".
Hysolv says a German calculation showed a reduction in margin of 83 Euros (£74) per sow, equivalent to 41,000 Euros (£32,500) for a 500-sow herd, due to oedema.
The booklet — printed on heavy duty glossy card – suitable for use in piggeries — is available, free, by visiting the Hysolv website: www.hysolv.co.uk
Defra has published an epidemiology report into the Avian Influenza outbreak confirmed in Oxfordshire on 4 June. The report concludes that, at as of 11th June, the outbreak was confined to a single premises, and there is no evidence of infection in the Protection Zone or of spread to any other premises. However, investigations continue. The report suggests that it is possible that the Highly Pathogenic H7N7 Avian influenza derived from a Low Pathogenic strain already present on the farm. Analysis and investigations are ongoing, and a number of source hypotheses are being considered. Chief Veterinary Officer, Nigel Gibbens, said: "The UK is at a constant but low level of risk of the introduction of Avian Influenza, and the report highlights the need for flock owners and poultry vets to remain vigilant for signs of disease, including the possibility of low pathogenic Avian Influenza. I would encourage all keepers to maintain good quality records and practise high standards of biosecurity." The Protection and Surveillance Zones remain in place. Further surveillance, testing and epidemiological work on this outbreak are ongoing.
The report can be viewed here:
http://www.defra.gov.uk/animalh/diseases/notifiable/disease/ai/latest-situation/index.htm
Defra has announced that the Bluetongue Protection Zone will be extended again on Monday 7 July, following the delivery by Intervet of almost 2 million additional doses of Bluetongue vaccine. Vaccination is only permitted within the Protection Zone. In accordance with the Bluetongue vaccination plan, the Protection Zone will be extended to cover all of the East Riding of Yorkshire (including the City of Kingston upon Hull), South Yorkshire (made up of the metropolitan boroughs of Barnsley, Doncaster, Rotherham and Sheffield), Gloucestershire (including the unitary authority of South Gloucestershire) and Warwickshire. Defra will continue to roll out vaccination as vaccine is delivered, in line with the vaccination roll-out plan. The additional vaccine is available for use in the existing Protection Zone from today. Livestock keepers in the areas coming into the Protection Zone will be able to obtain the vaccine from Monday. However, they are encouraged to order vaccine so that they can protect their livestock at the earliest opportunity. Protection Zone restrictions will apply to those keepers coming into the extended zone. Animals can only be moved out of the Protection Zone if they are vaccinated, naturally immune or moving for slaughter, subject to meeting certain conditions. Animals will also be able to be moved between the Protection Zones in Wales and England, subject to the conditions on the transit licence.
The solution is designed to streamline Animal Health and Welfare Pathway (AHWP) reviews, from on-farm sampling through to laboratory results, reporting, vet attestation and DEFRA compliance, by integrating faecal egg count testing at Sandhill Laboratories with the VetDX app,
VetDX says that by integrating every stage of the review process into a single digital workflow, the VetDX platform allows practices to carry out efficient, compliant visits with a reduced administrative burden.
Laura Eden MRCVS (pictured), farm animal vet at Bishopton Vets said: “What’s really improved the process for us is how straightforward it is to submit samples and how quickly we get results back from Sandhill.
"It takes a lot of the hassle out of coordinating AHWP visits and lets us focus on the clinical side.”
Rachel Kirkby MRCVS, Business Development Director at VetDX, said: “The AHWP is a real opportunity to tackle issues like anthelmintic resistance in a structured, funded way - but only if the process is workable on the ground.
"That’s why we’ve built the platform to fit naturally into how vets carry out these visits, supporting accurate on-farm data capture with features like in-app QR code scanning.
"It means lab results are securely linked to the right animals or groups, without the risk of transcription errors or lost paperwork.”
https://vetdxs.com